Biologicals

Vaccine Standardization

The World Health Organization brings together international experts in specific fields through its biological standardization programme to develop and revise specific recommendations for the production and quality control of vaccines of major international public health importance. Authoritative, harmonized guidelines and recommendations, for use by manufacturers and regulatory authorities, are published in the reports of ECBS meetings in the WHO Technical Report Series. These include recommendations for individual vaccines, and also more general guidelines on technical or regulatory topics such as cell substrates, nonclinical evaluation, or clinical evaluation. This programme also establishes and distributes the WHO Biological Reference Materials required for the standardization of assays to laboratories around the world such as manufacturers and National Control Laboratories (NCLs) who are involved in the quality control of vaccines. This activity is critical to ensure the quality of essential vaccines in a global market.

Vaccine-specific standardization

General topics and regulatory guidance


Biological Therapeutic Products

NEW PUBLICATIONS

RECENT PUBLICATIONS

UPCOMING EVENTS

WHO Implementation Workshop: Characterization of cell banks for the production of biologicals, 27-29 May 2013 and WHO Informal Consultation on regulatory risk assessment in the case of adventitious agent finding in a marketed vaccine, 30-31 May 2013, Beijing, Republic of China

WHO Informal Consultation on the Scientific and Regulatory Considerations on the Stability Evaluation of Vaccines under a Controlled Temperature Chain, Langen, Germany, 4-6 June 2013

Expert Committee on Biological Standardization, Geneva, Switzerland, 21-25 October 2013

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971